D.S. DruzhilovskiyП.И. СавосинаО. А. ГомазковBoris N. SobolevAlexander V. VeselovskyOlga TarasovaNadezhda BiziukovaН. С. ИоновSergey M. IvanovAnastasia V. RudikLeonid StolbovPavel V. PogodinDmitry А. KarasevD.A. DmitrievAlexey A. LaguninDmitry Filimonov
Drug repositioning – the discovery of new indications for the launched drugs – is the rapid natural response to viral infection SARS-CoV-2/COVID-19. We will consider the current state of research and development of repositioned pharmaceuticals for the therapy of COVID-19 using in silico and in vitro methods.
П.И. СавосинаДмитрий Сергеевич ДружиловскийVladimir Poroikov
Chandana MohantyCh. VinodSarbari AcharyaNikita Mahapatra